Castle Biosciences Inc. (CSTL)
27.50
0.44 (1.63%)
At close: Jan 29, 2025, 3:59 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| PE Ratio | -10.06 | -9.14 | -34.44 | -123.6 | 55.91 | -35.8 | -16.93 |
| PS Ratio | 2.63 | 4.48 | 11.45 | 20.29 | 5.69 | 10.00 | 15.22 |
| PB Ratio | 1.48 | 1.54 | 2.62 | 3.06 | 3.47 | -22.64 | -14.67 |
| P/FCF Ratio | -30.05 | -12.97 | -47.97 | 248.55 | 48.54 | -18.13 | -16.45 |
| P/OCF Ratio | -102.81 | -14.72 | -56.77 | 128.85 | 42.06 | -18.54 | -17.12 |
| OCF/S Ratio | -0.03 | -0.3 | -0.2 | 0.16 | 0.14 | -0.54 | -0.89 |
| Debt / Equity Ratio | 0.04 | 0.03 | 0.02 | n/a | 0.30 | -2.43 | -1.3 |
| Quick Ratio | 6.04 | 7.98 | 14.13 | 20.47 | 7.55 | 2.56 | 1.22 |
| Current Ratio | 6.20 | 8.09 | 14.21 | 20.58 | 7.63 | 2.69 | 1.28 |
| Asset Turnover | 0.48 | 0.31 | 0.20 | 0.14 | 0.43 | 1.02 | 1.40 |
| Interest Coverage | -6.18K | -5.36K | -40.08K | -2.48 | 1.03 | -1.69 | -6.61 |
| Return on Equity (ROE) | -0.15 | -0.17 | -0.08 | -0.02 | 0.06 | 0.63 | 0.87 |
| Return on Assets (ROA) | -0.13 | -0.15 | -0.07 | -0.02 | 0.04 | -0.28 | -1.26 |
| Return on Capital (ROIC) | -0.17 | -0.22 | -0.09 | -0.02 | 0.05 | -0.24 | -2.37 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 79.53% | 76.64% | 83.18% | 84.54% | 85.91% | 76.75% | 64.21% |
| Net Profit Margin | -26.15% | -48.99% | -33.26% | -16.42% | 10.17% | -27.94% | -89.93% |
| Pretax Profit Margin | -26.1% | -50.28% | -42.53% | -16.28% | 10.31% | -27.91% | -89.86% |
| Operating Profit Margin | -30.93% | -66.51% | -42.6% | -10.44% | 9.08% | -16.83% | -79.25% |
| FCF Margin | -8.76% | -34.51% | -23.88% | 8.16% | 11.72% | -55.17% | -92.54% |
| EBITDA Margin | -20.49% | -42.57% | -38.91% | -11.32% | 14.82% | -16.51% | -75.61% |